Camac Fund, LP's Form 4 filing
Pasithea Therapeutics Corp. (KTTA) · filed Sep 6, 2022
- Accession no.
- 0001209191-22-048789
- Filed
- Sep 6, 2022, 5:03 PM ET
- Trade date
- Sep 1-6, 2022
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $100.4K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Camac Fund, LPCIK 0001516478 | Other: Member of 10% owner group |
| Shahinian EricCIK 0001790877 | Other: Member of 10% owner group |
| Camac Partners, LLCCIK 0001867496 | Other: Member of 10% owner group |
| Camac Capital, LLCCIK 0001867498 | Other: Member of 10% owner group |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2022 | Common Stock | PPurchaseAcquired | +55,646 | $1.13 | +$62,629.57 | 1,690,803 | Indirect | |
| Sep 2, 2022 | Common Stock | PPurchaseAcquired | +11,507 | $1.14 | +$13,105.32 | 1,702,310 | Indirect | |
| Sep 6, 2022 | Common Stock | PPurchaseAcquired | +21,748 | $1.13 | +$24,631.78 | 1,724,058 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.